Shanghai CP GENERAL Pharmaceutical Co., Ltd. | Pharmaceutical Manufacturer Profile & Drug Portfolio

Fluocinolone acetonide cream

The main component of this product is fluocinolone acetate. Its chemical name is: 11beta-hydroxy-16alpha, 17-[(1-methylethylidene)-bis(oxy)]-21-(acetoxy)-6alpha, 9-difluoropregnane-1,4-diene-3,20-dione.

Name	Description	Content	CAS NO.	Registered Holders
Fluocinonide	Adrenal cortex hormone drugs. External use can shrink dermal capillaries, inhibit the proliferation or regeneration of epidermal cells, inhibit the regeneration of fibroblasts in connective tissue, stabilize intracellular lysosomal membranes, and prevent tissue damage caused by the release of lysosomal enzymes. It has strong anti-inflammatory and anti-allergic effects. More Adrenal cortex hormone drugs. External use can shrink dermal capillaries, inhibit the proliferation or regeneration of epidermal cells, inhibit the regeneration of fibroblasts in connective tissue, stabilize intracellular lysosomal membranes, and prevent tissue damage caused by the release of lysosomal enzymes. It has strong anti-inflammatory and anti-allergic effects.		356-12-7	14

Fluocinolone acetonide cream

The main component of this product is fluocinolone acetate. Its chemical name is: 11beta-hydroxy-16alpha, 17-[(1-methylethylidene)-bis(oxy)]-21-(acetoxy)-6alpha, 9-difluoropregnane-1,4-diene-3,20-dione.

Name	Description	Content	CAS NO.	Registered Holders
Fluocinonide	Adrenal cortex hormone drugs. External use can shrink dermal capillaries, inhibit the proliferation or regeneration of epidermal cells, inhibit the regeneration of fibroblasts in connective tissue, stabilize intracellular lysosomal membranes, and prevent tissue damage caused by the release of lysosomal enzymes. It has strong anti-inflammatory and anti-allergic effects. More Adrenal cortex hormone drugs. External use can shrink dermal capillaries, inhibit the proliferation or regeneration of epidermal cells, inhibit the regeneration of fibroblasts in connective tissue, stabilize intracellular lysosomal membranes, and prevent tissue damage caused by the release of lysosomal enzymes. It has strong anti-inflammatory and anti-allergic effects.		356-12-7	14

Bifonazole cream

Each gram of this product contains 10 mg of the main ingredient bifonazole, and the auxiliary materials are stearic acid, glyceryl monostearate, octadecyl alcohol, cetyl alcohol, Span 60, propylene glycol, glycerin, emulsified silicone oil, potassium lauryl phosphate, Germa A, and purified water.

Name	Description	Content	CAS NO.	Registered Holders
Bifonazole	This product is a broad-spectrum antifungal drug. Its mechanism of action is to inhibit the synthesis of cell membranes. It has antibacterial effects on dermatophytes and Candida. More This product is a broad-spectrum antifungal drug. Its mechanism of action is to inhibit the synthesis of cell membranes. It has antibacterial effects on dermatophytes and Candida.	10mg	60628-96-8	11

Bifonazole cream

Each gram of this product contains 10 mg of the main ingredient bifonazole, and the auxiliary materials are stearic acid, glyceryl monostearate, octadecyl alcohol, cetyl alcohol, Span 60, propylene glycol, glycerin, emulsified silicone oil, potassium lauryl phosphate, Germa A, and purified water.

Name	Description	Content	CAS NO.	Registered Holders
Bifonazole	This product is a broad-spectrum antifungal drug. Its mechanism of action is to inhibit the synthesis of cell membranes. It has antibacterial effects on dermatophytes and Candida. More This product is a broad-spectrum antifungal drug. Its mechanism of action is to inhibit the synthesis of cell membranes. It has antibacterial effects on dermatophytes and Candida.	10mg	60628-96-8	11

Estradiol Benzoate Injection

The main ingredient of this product is estradiol benzoate. Its chemical name is: 3-hydroxyestrone-1,3,5 (10)-triene-17beta;-ol-3-benzoate. Its structural formula is: Molecular formula: C25H28O3 Molecular weight: 376.50

Name	Description	Content	CAS NO.	Registered Holders
Estradiol benzoate	Estrogen drugs. They can cause endometrial hyperplasia, enhance uterine smooth muscle contraction, and promote breast development and hyperplasia. Large doses inhibit the release of prolactin, counteract the effects of androgens, and increase calcium deposition in bones. More Estrogen drugs. They can cause endometrial hyperplasia, enhance uterine smooth muscle contraction, and promote breast development and hyperplasia. Large doses inhibit the release of prolactin, counteract the effects of androgens, and increase calcium deposition in bones.		50-50-0	9